The researchers wanted to determine if high-resolution micro-ultrasonography-guided biopsy was better than MRI fusion-guided biopsy for detecting prostate cancer in a clinical setting. The study found ...

Grade Group ≥2 prostate cancer was detected in 57 of 121 patients in the microultrasonography group, 141 of 331 patients in the MRI/US-fusion group, and 106 of 226 in the MRI ...

Patients underwent MRI with a 3.0-T scanner (Achieva 3.0-T TX series R3.21; Philips Medical Systems, Best, the Netherlands) and a pelvic phased-array coil (32-channel SENSE Torso/Cardiac Coil). No ...

MRI-invisible prostate lesions. It sounds like the stuff of science fiction and fantasy, a creation from the minds of H.G. Wells, who wrote The Invisible Man, or J.K. Rowling, who authored the ...

The team included and monitored nearly 600 patients with suspected prostate cancer in their study. The subjects underwent multiparametric magnetic resonance imaging (mpMRI) at Charité.

Magnetic resonance imaging found no suspicious lesions 367 days after irreversible electroporation. At the final clinical follow-up at 390 days, the patient was asymptomatic. Our findings illustrate ...

Over approximately 26,000 person-years, any prostate cancer (2.8% vs 4.5%) and clinically insignificant grade group 1 prostate cancer (1.0% vs 2.4%) were detected in lower proportions of the MRI ...

Put another way, using the MRI-targeted approach would spare 51 men from undergoing biopsy and 14 men from receiving grade 1 prostate cancer diagnoses out of every 1,000 men.

The rectal wall is very visible, the bladder wall, the urethra. I think with the extreme accuracy of the MRI scan, we can deliver treatments much more accurately and spare the organs around the ...

AI better detects prostate cancer on MRI than radiologists Computer detects prostate cancer more often and has reduced false alarm Date: June 12, 2024 Source: Radboud University Medical Center ...

More information: Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study, The Lancet Oncology (2024).

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham ...